Brandywine Global Investment Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Brandywine Global Investment Management’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$347K	Hold	39,390	–	–	﹤0.01%	571
2025 Q3	$197K	Hold	39,390	–	–	﹤0.01%	591
2025 Q2	$186K	Hold	39,390	–	–	﹤0.01%	564
2025 Q1	$181K	Hold	39,390	–	–	﹤0.01%	548
2024 Q4	$189K	Buy	39,390 +4,820	+14%	+$23.1K	﹤0.01%	547
2024 Q3	$166K	Buy	+34,570	New	+$185K	﹤0.01%	652
2023 Q1	–	Sell	-148,219	Closed	-$1.1M	–	771
2022 Q4	$1.1M	Buy	+148,219	New	+$1.44M	0.01%	634
2018 Q4	–	Sell	-47,353	Closed	-$1.09M	–	898
2018 Q3	$1.09M	Buy	47,353 +71	+0.2%	+$1.45K	0.01%	562
2018 Q2	$901K	Sell	47,282 -1,117	-2%	-$18.7K	0.01%	590
2018 Q1	$816K	Buy	+48,399	New	+$810K	0.01%	589

Other funds holding VNDA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

KAM

Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return

Brandywine Global Investment Management's VNDA Position: Q4 2025 in Review

Brandywine Global Investment Management held its Vanda Pharmaceuticals (VNDA) position steady in Q4 2025 at 39,390 shares worth $347K. The position accounts for ﹤0.01% of the portfolio, ranked #571.

Brandywine Global Investment Management first reported a position in VNDA in Q1 2018 and has held it in 10 quarters since. The position peaked at $1.1M in Q4 2022. 153 funds tracked by Wall St. Rank hold VNDA as of Q4 2025.

Brandywine Global Investment Management held 39,390 shares of Vanda Pharmaceuticals worth $347K as of Q4 2025.
Brandywine Global Investment Management left its Vanda Pharmaceuticals share count unchanged in Q4 2025.
Vanda Pharmaceuticals made up ﹤0.01% of Brandywine Global Investment Management's portfolio in Q4 2025, its #571 holding.
Brandywine Global Investment Management first reported a position in Vanda Pharmaceuticals in Q1 2018 and has held it in 10 quarters since.
Brandywine Global Investment Management's Vanda Pharmaceuticals position peaked at $1.1M in Q4 2022.
153 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2025.

Based on Brandywine Global Investment Management's 13F filing for Q4 2025, filed 11 Feb 2026.